Why the study?
Does central obesity increase the risk of adverse cardiovascular outcomes in patients with acute coronary syndrome?
Population
Patients with acute coronary syndrome (observations from the MERLIN-TIMI 36 trial)
Comparison
Central obesity vs Lack of central obesity
Design
Cohort
Authors
Loading...
May refine post-ACS risk stratification beyond BMI; hypothesis-generating and requires prospective validation.
Does central obesity increase the risk of adverse cardiovascular outcomes in patients with acute coronary syndrome?
Central adiposity, indicated by waist circumference out of proportion to BMI, may identify patients at highest risk for adverse cardiovascular outcomes following ACS, challenging the short-term obesity paradox.
Kadakia et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: